Skip to main content
HR 4669 114th Congress House Health Cell biology and embryology Drug safety, medical device, and laboratory regulation Genetics Medical research Organ and tissue donation and transplantation Public-private cooperation

Advancing Standards in Regenerative Medicine Act

Introduced: March 2, 2016 Introduced by: Foster, Bill Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 4, 2016
Referred to the Subcommittee on Health.
Mar 2, 2016
Referred to the House Committee on Energy and Commerce.
Mar 2, 2016
Introduced in House
 Plain-English summary Congressional Research Service

Advancing Standards in Regenerative Medicine Act

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.
What's happening now March 4, 2016

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2